The Canadian Pari-Mutuel Agency (CPMA) has officially added bupivacaine to paragraph 1(d) of the Schedule to the Pari-Mutuel Betting Supervision Regulations. This drug was previously prohibited under paragraph 1(b) as a human drug.
This change is due to the recent approval of a veterinary product containing bupivacaine by Health Canada. Rilmazafone
Bupivacaine is a local anesthetic similar to lidocaine and mepivacaine and is used to block pain.
To receive Canadian Pari-Mutuel Agency email notifications or to unsubscribe from the distribution list send an email to aafc.cpmawebacpm.aac@agr.gc.ca .
From the Canadian Pari-Mutuel Agency
Harnesslink.com is the only harness racing website dedicated to covering news and events in the Standardbred Industry world-wide.
Contact Us Disclaimers Privacy Policy Terms & Conditions
© 2021 Harnesslink | All Rights Reserved | NV
Dht Testosterone © 2022 Harnesslink | All Rights Reserved | NV.